Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Medullary × Calcium Aluminosilicate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diarrhea 1 Carcinoma, Medullary 1

Interventions

vandetanib 3 selpercatinib 2 pralsetinib 1 Peripheral Blood Stem Cell Transplantation 1 Indium 1 Imatinib Mesylate 1 Filgrastim 1 Doxorubicin 1 Dacarbazine 1 Capecitabine 1 Calcium Aluminosilicate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01739634 2012-12-03

The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

Salient Pharmaceuticals Incorporated

Phase 1/2 Unknown

Diarrhea, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡